Table 2.
Gene | Gene name | Syndromea | Original ClinGen curation GCEP | Original classification | Genetic evidence for PAH | Variant type scoredb | Experimental evidence for PAH | Evidence type scoredc | Total score for PAH | >3 yrs | Classification for PAH |
---|---|---|---|---|---|---|---|---|---|---|---|
ACVRL1 | Activin receptor like 1 | HHT | Hemostasis/ thrombosis | Definitive | 12 | pLOF, missense | 6 | F/expression, biochemical, interaction; M/non-human | 16 | Y 2001 | Definitive |
ENG | Endoglin | HHT | Hemostasis/ thrombosis | Definitive | 10.1 | pLOF, missense, other | 3.5 | F/expression, interaction; M/nonhuman | 13.6 | Y 2003 | Definitive |
TBX4 | T-box transcription factor 4 | TBX4 syndrome | --- | --- | 12 | pLOF | 1 | F/expression; FA/patient, non-patient | 13 | Y 2013 | Definitive |
HHT, hereditary hemorrhagic telangiectasia
pLOF, predicted loss of function, including nonsense, frameshift, and canonical splice variants..
F, function (relevant expression, biochemical function, protein interaction); FA, functional alteration (in patient or non-patient cells); M, model (human or non-human, cell culture/human or non-human); R, rescue. (human or non-human, cell culture/human or non-human)